PCN56 NAB-PACLITAXEL OR DOCETAXEL; AS ALTERNATIVES TO CONVENTIONAL PACLITAXEL FOR THE TREATMENT OF METASTATIC BREAST CANCER (MBC)- A COST UTILITY ANALYSIS IN FIVE EUROPEAN COUNTRIES
Abstract
Authors
G Dranitsaris M Lidgren J Lundkvist R Coleman